Clinical Trial Update: Atenativ Effect on Uterine Blood Flow and Preeclampsia [Phase 4]

View source ↗

Summary

Phase 4 trial update for Atenativ assessing uterine blood flow and preeclampsia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antithrombin Iii Deficiency

Drugs mentioned

• Atenativ

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Antithrombin III Deficiency | Phase 4 | Status: WITHDRAWN